Beta Drugs Limited (NSE:BETA)
India
· Delayed Price · Currency is INR 1,073.90
-24.10 (-2.19%)
At close: Mar 9, 2026
Beta Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,841 | 19,235 | 11,861 | 6,027 | 5,437 | 1,038 | Upgrade
|
| Market Cap Growth | -36.63% | 62.17% | 96.79% | 10.87% | 423.79% | 200.00% | Upgrade
|
| Enterprise Value | 11,072 | 19,147 | 11,782 | 6,023 | 5,446 | 1,127 | Upgrade
|
| Last Close Price | 1073.90 | 1905.50 | 1175.00 | 597.10 | 538.57 | 114.29 | Upgrade
|
| PE Ratio | 27.16 | 45.35 | 32.55 | 19.62 | 21.90 | 8.85 | Upgrade
|
| PS Ratio | 2.82 | 5.31 | 4.01 | 2.65 | 2.96 | 0.89 | Upgrade
|
| PB Ratio | 4.90 | 9.76 | 7.55 | 4.91 | 5.89 | 1.51 | Upgrade
|
| P/TBV Ratio | 5.12 | 10.20 | 7.82 | 5.10 | 6.17 | 1.59 | Upgrade
|
| P/FCF Ratio | - | - | 61.41 | 116.57 | 53.30 | 8.08 | Upgrade
|
| P/OCF Ratio | - | 53.22 | 38.35 | 25.78 | 18.35 | 5.58 | Upgrade
|
| EV/Sales Ratio | 2.88 | 5.28 | 3.98 | 2.65 | 2.96 | 0.97 | Upgrade
|
| EV/EBITDA Ratio | 14.93 | 26.06 | 19.67 | 11.27 | 12.75 | 4.55 | Upgrade
|
| EV/EBIT Ratio | 18.63 | 30.84 | 23.50 | 14.00 | 15.37 | 6.29 | Upgrade
|
| EV/FCF Ratio | - | - | 61.00 | 116.49 | 53.39 | 8.77 | Upgrade
|
| Debt / Equity Ratio | 0.66 | 0.70 | 0.09 | 0.17 | 0.22 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 1.96 | 1.88 | 0.25 | 0.38 | 0.48 | 0.70 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.76 | 3.93 | 2.02 | 1.36 | Upgrade
|
| Net Debt / Equity Ratio | 0.11 | -0.05 | -0.09 | 0.01 | 0.04 | 0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.31 | -0.12 | -0.23 | 0.02 | 0.08 | 0.28 | Upgrade
|
| Net Debt / FCF Ratio | - | 12.56 | -0.72 | 0.23 | 0.32 | 0.55 | Upgrade
|
| Asset Turnover | - | 1.05 | 1.31 | 1.27 | 1.34 | 1.03 | Upgrade
|
| Inventory Turnover | - | 3.88 | 4.51 | 4.88 | 5.83 | 5.09 | Upgrade
|
| Quick Ratio | - | 2.54 | 1.42 | 1.43 | 1.42 | 1.45 | Upgrade
|
| Current Ratio | - | 3.22 | 2.10 | 2.03 | 1.98 | 2.04 | Upgrade
|
| Return on Equity (ROE) | - | 23.95% | 26.03% | 28.54% | 30.85% | 18.65% | Upgrade
|
| Return on Assets (ROA) | - | 11.24% | 13.85% | 15.10% | 16.09% | 9.97% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.41% | 27.91% | 28.04% | 29.31% | 29.96% | 17.56% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 18.60% | 29.60% | 31.80% | 32.60% | 21.30% | Upgrade
|
| Earnings Yield | 3.83% | 2.21% | 3.07% | 5.10% | 4.57% | 11.30% | Upgrade
|
| FCF Yield | - | -0.04% | 1.63% | 0.86% | 1.88% | 12.38% | Upgrade
|
| Buyback Yield / Dilution | -10.48% | -5.00% | 4.76% | - | - | -1.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.